-
Sponsored by Spoor & FisherNew patent and utility model procedures and updated fees form part of a legislative update to the Bangui Agreement that became effective in the new year, explains Craig Kahn of Spoor & Fisher Jersey -
Sponsored by Spoor & FisherMatthew Costard of Spoor & Fisher Jersey considers application of the Madrid Protocol across Africa as Ethiopia’s intellectual property practice looks set to move closer to global standards
-
Sponsored by Adams & AdamsJames Davies and Vishen Pillay at Adams & Adams discuss IP protection strategies and ownership considerations for AI
-
Sponsored by Tilleke & GibbinsKhemphet Phonphakdy and Saithong Rattana of Tilleke & Gibbins summarise the changes under the latest revision as Laos aims to attract foreign investment and align its intellectual property laws with international standards
-
Sponsored by Tilleke & GibbinsWongrat Ratanaprayul of Tilleke & Gibbins highlights the complex processes required to secure AI patents across Southeast Asia
-
Sponsored by Tilleke & GibbinsSukontip Jitmongkolthong and Saithong Rattana of Tilleke & Gibbins describe how Laos has improved its framework to enforce IP rights through border measures
-
Sponsored by IPSILONJoran Michiels of IPSILON Belgium examines how recent EPO and UPC decisions may support inventive-step arguments for CARs, ADCs, bispecific antibodies, and other next-generation therapeutics
-
Sponsored by InspicosPeter Koefoed of Inspicos examines how the EPO Enlarged Board of Appeal referral G 1/26 could clarify the application of G 1/24 when assessing the allowability of amended patent claims under the EPC
-
Sponsored by MaiwaldAlexander Ortlieb, Moritz Kampmann, and Stephan Maidl of Maiwald highlight six EPO appeal decisions that map the absolute floor of what patent applications for AI inventions must disclose – and how spectacularly some applicants miss that mark
-
Sponsored by Daniel LawRafael Salomão Romano and Samantha Salim of Daniel Law outline how the instructions will improve transparency and accountability in the Brazilian pharmaceutical patent scene
-
Sponsored by OLIVARESIt is important not to forget that the Civil Code states that debtors respond to the fulfilment of their obligations with their assets, except for all those assets considered by law as inalienable or which cannot be seized.
-
Sponsored by Daniel LawIn view of its very large territory, Brazil has always faced many challenges implementing a successful anti-counterfeiting programme. Lack of a uniform approach and the absence of a political will to tackle IP infringements on a large scale were some of the problems that held IP owners back in the past.
-
Sponsored by Red PointsRed Points, in partnership with Managing IP hosted a webinar on April 7 at 9am PDT / 12pm EDT / 5pm BST to discuss best practices in uncovering and dismantling large-scale counterfeiters
-
Sponsored by OLIVARESMauricio Sámano of OLIVARES explores how the pandemic has changed IP processes for businesses in Mexico
-
Sponsored by OLIVARESSantiago Pedroza of OLIVARES looks at how the opposition procedure has undergone changes to protect right holders
-
Sponsored by Cabinet M OproiuRaluca Vasilescu of Cabinet M Oproiu considers how AI and pricing pressures could affect patent attorneys’ work in the near future
-
Sponsored by Bird & BirdNick Aries of Bird & Bird LLP examines how agentic AI could reshape brand discovery, trademark enforcement, and comparative advertising, and outlines key risks for brand owners
-
Sponsored by NLOTariq Shajahan and Willem Niesing of NLO analyse dredging-related patent filings in key jurisdictions and highlight contrasting Western and Asian approaches to innovation, from component-level engineering to system-wide methodologies and AI-driven optimisation
